Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak

Aminian, A. and Kermansaravi, M. and Azizi, S. and Alibeigi, P. and Safamanesh, S. and Mousavimaleki, A. and Rezaei, M.T. and Faridi, M. and Mokhber, S. and Pazouki, A. and Safari, S. (2020) Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. Obesity Surgery, 30 (9). pp. 3624-3627.

Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.pdf

Download (297kB) | Preview
Official URL:


There is no data on patients with severe obesity who developed coronavirus disease 2019 (COVID-19) after bariatric surgery. Four gastric bypass operations, performed in a 2-week period between Feb 24 and March 4, 2020, in Tehran, Iran, were complicated with COVID-19. The mean age and body mass index were 46 ± 12 years and 49 ± 3 kg/m2. Patients developed their symptoms (fever, cough, dyspnea, and fatigue) 1, 2, 4, and 14 days after surgery. One patient had unnoticed anosmia 2 days before surgery. Three patients were readmitted in hospital. All 4 patients were treated with hydroxychloroquine. In two patients who required admission in intensive care unit, other off-label therapies including antiretroviral and immunosuppressive agents were also administered. All patients survived. In conclusion, COVID-19 can complicate the postoperative course of patients after bariatric surgery. Correct diagnosis and management in the postoperative setting would be challenging. Timing of infection after surgery in our series would raise the possibility of hospital transmission of COVID-19: from asymptomatic patients at the time of bariatric surgery to the healthcare workers versus acquiring the COVID-19 infection by non-infected patients in the perioperative period. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Item Type: Article
Additional Information: cited By 7
Uncontrolled Keywords: amoxicillin plus clavulanic acid; hydroxychloroquine; lopinavir plus ritonavir; tocilizumab; antiretrovirus agent; immunosuppressive agent, adult; anosmia; Article; bariatric surgery; case report; clinical article; clinical practice; coronavirus disease 2019; coughing; dyspnea; epidemic; fatigue; female; fever; hemoperfusion; human; male; middle aged; obesity; priority journal; treatment outcome; x-ray computed tomography; Betacoronavirus; Coronavirus infection; gastric bypass surgery; hospital readmission; Iran; off label drug use; pandemic; postoperative complication; virology; virus pneumonia, Adult; Anti-Retroviral Agents; Betacoronavirus; Coronavirus Infections; Cough; Dyspnea; Fatigue; Female; Fever; Gastric Bypass; Humans; Hydroxychloroquine; Immunosuppressive Agents; Iran; Male; Middle Aged; Off-Label Use; Pandemics; Patient Readmission; Pneumonia, Viral; Postoperative Complications
Subjects: WC Communicable Diseases
WD Disorders of Systemic, Metabolic or Environmental Origin, etc.
Depositing User: eprints admin
Date Deposited: 03 Oct 2020 05:38
Last Modified: 03 Oct 2020 05:38

Actions (login required)

View Item View Item